Global Kras Inhibitors Market è segmentato Da Drug Type (Small Molecule Inhibitors, Monoclonal Antibodies, Combination Therapies), Da Indication (Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer, Pancreatic Cancer), By Route of Administration (Oral, Intravenous, Others), By Cancer Type Cancer (Lung Cancer, Middle Cancer, Colorectal Cancer End, Other By Il rapporto offre il valore (in milioni di dollari) per i suddetti segmenti.